5/
🧬 Rare variants can be game-changing. Genome sequencing can yield answers in up to 30% of patients with ASD or intellectual disability.
Our paper outlines how to interpret these findings—and when to test.
🧬 Rare variants can be game-changing. Genome sequencing can yield answers in up to 30% of patients with ASD or intellectual disability.
Our paper outlines how to interpret these findings—and when to test.
Comments
đź’Š What about pharmacogenetics?
We separate hype from evidence, outlining when pharmacogenetic data should influence psychotropic prescribing—and when it shouldn't.
Spoiler: Not all “green box” meds are created equal.
🧠Genetic counseling is more than testing. It’s about empowering patients with knowledge, reducing stigma, and making informed choices.
We champion integration of genetic counseling into psychiatric training.
⚠️ Finally, we discuss the fraught history—and real risks—of genetic stigma and misuse. From eugenics to polygenic embryo screening, we urge clinicians to tread carefully and ethically.
Science ≠policy.
đź“š This paper is a resource, a roadmap, and a call to action for psychiatrists, psychologists, social workers, nurses, and beyond.
Read it here:
đź”— https://psychiatryonline.org/doi/10.1176/appi.ajp.20240295
@danielmorenodeluca.bsky.social